A. Ginde

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Adit a. Ginde, A A Ginde, Adit A. Ginde, A. A. Ginde, A. Ginde, A.a. Ginde, Adit Ginde, Adit A Ginde, A Ginde
Publication record
398 papers · 21,884 citations · H-index 67

PAPERS

Abstract DP220: Neuroinflammatory Cascade in First 24 Hours after Acute Ischemic Stroke Predicts Early Outcome: Circulating Inflammatory Factors Obtained on a Mobile Stroke Unit
20260 citationsauthor #9
Randomized trial of activated vitamin D for acute kidney injury prevention in critically ill patients
20250 citationsauthor #7
Circulating Interleukin‐6 Levels and Timing of Acute Ischemic Stroke Onset
20253 citationsauthor #11
235 Root cause analysis of barriers and facilitators to accrual to a pragmatic, EHR-embedded clinical trial
20250 citationsauthor #3
Psychological distress in clinical research professionals in acute care settings: Potential risks and future directions
20250 citationsauthor #3
Effect of targeting normoxemia on supplemental oxygen-free days for adults with acute thermal burns: A stepped wedge cluster randomized clinical trial.
20251 citationsauthor #24
Identification of HIF1A as a therapeutic target during SARS-CoV-2–associated lung injury
20253 citationsauthor #15
External Validation of a Novel Lung Injury Prevention Score for the Emergency Department
20250 citationsauthor #3
Association between community assault and adverse renal outcomes among patients with crush injury in South Africa: a retrospective cohort study
20250 citationsauthor #21
Community Consultation and Public Disclosure for the Randomized Trial of Sedative Choice for Intubation
20250 citationsauthor #6
An End-user Assessment of the Novel i-view Video Laryngoscope After a Clinical Trial.
20250 citationsauthor #8
P-2069. Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against COVID-19–associated Hospitalization Among Adults — IVY Network, 20 U.S. States
20250 citationsauthor #9
Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
20254 citationsauthor #16
Prochlorperazine maleate versus placebo for the prophylaxis of Acute Mountain sickness: a double-blind randomized controlled trial.
20252 citationsauthor #18
Experiences of recently diagnosed urban COVID-19 outpatients: A survey on patient worries, provider-patient interactions, and neutralizing monoclonal antibody treatment
20250 citationsauthor #10
A prospective, pragmatic non‐inferiority study of emergency intubation success with the single‐use i‐view versus standard reusable video laryngoscope
20241 citationsauthor #10
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
202411 citationsauthor #8
Lessons Learned from National Heart, Lung, and Blood Institute Covid-19 Clinical Trials.
20241 citationsauthor #18
Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study
20245 citationsauthor #16
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.
202422 citationsauthor #13
Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States
202470 citationsauthor #21
Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data
202411 citationsauthor #16
Effectiveness of subcutaneous monoclonal antibody treatment in emergency department outpatients with COVID‐19
20242 citationsauthor #13
Upstrapping to determine futility: predicting future outcomes nonparametrically from past data
20240 citationsauthor #2
Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5
20249 citationsauthor #12
Effectiveness of Original Monovalent and Bivalent COVID‐19 Vaccines Against COVID‐19‐Associated Hospitalization and Severe In‐Hospital Outcomes Among Adults in the United States, September 2022–August 2023
20246 citationsauthor #10
Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024
202457 citationsauthor #30
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
202424 citationsauthor #13
Time to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo
20244 citationsauthor #16
Association between monoclonal antibody therapy, vaccination, and longer‐term symptom resolution after acute COVID‐19
20241 citationsauthor #12
Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States -- September 2022-August 2023
20244 citationsauthor #10
Rapid methods for multi-level dissemination of neutralizing monoclonal antibody treatment for COVID-19 outpatients: designing for dissemination using the fit to context framework
20241 citationsauthor #4
Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials.
20243 citationsauthor #18
Association between multiple intubation attempts and complications during emergency department airway management: A national emergency airway registry study.
202411 citationsauthor #6
A Machine Learning Method for Allocating Scarce COVID-19 Monoclonal Antibodies
20242 citationsauthor #13
Noninvasive Ventilation for Preoxygenation during Emergency Intubation.
202476 citationsauthor #57
Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents.
20243 citationsauthor #2
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses - IVY Network, September 1, 2022-March 30, 2023.
20245 citationsauthor #32
Interventions associated with survival after prehospital intubation in the deployed combat setting.
20242 citationsauthor #7
Shock prediction with dipeptidyl peptidase-3 and renin (SPiDeR) in hypoxemic patients with COVID-19.
20242 citationsauthor #16
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults
202447 citationsauthor #10
Evaluation of the feasibility and efficacy of point-of-care antibody tests for biomarker guided management of COVID-19.
20240 citationsauthor #10
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
202427 citationsauthor #95
Effectiveness of the original monovalent mRNA COVID-19 vaccination series against hospitalization for COVID-19-associated venous thromboembolism.
20240 citationsauthor #16
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
202427 citationsauthor #11
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022
202311 citationsauthor #21
Total and subgenomic RNA viral load in patients infected with SARS-CoV-2 Alpha, Delta, and Omicron variants.
20237 citationsauthor #20
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19: A Randomized Clinical Trial.
202360 citationsauthor #26
Provider Perceptions of Oxygenation Strategies for Critically Ill Trauma Patients With and Without Moderate-to-Severe Traumatic Brain Injury.
20231 citationsauthor #10
DirEct versus VIdeo LaryngosCopE (DEVICE): protocol and statistical analysis plan for a randomised clinical trial in critically ill adults undergoing emergency tracheal intubation
20238 citationsauthor #39
Defining Successful Intubation on the First Attempt Using Both Laryngoscope and Endotracheal Tube Insertions: A Secondary Analysis of Clinical Trial Data.
20235 citationsauthor #23
Improving prehospital traumatic shock care: implementation and clinical effectiveness of a pragmatic, quasi-experimental trial in a resource-constrained South African setting
20232 citationsauthor #16
Hyperoxemia During Cardiac Surgery Is Associated With Postoperative Pulmonary Complications
20232 citationsauthor #7
Effectiveness of Sotrovimab in Preventing COVID-19-Related Hospitalizations or Deaths Among US Veterans During Omicron BA.1.
20233 citationsauthor #11
Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study
202310 citationsauthor #3
Protocol and statistical analysis plan for the PREOXI trial of preoxygenation with noninvasive ventilation vs oxygen mask
20231 citationsauthor #2
Hyperoxia is associated with a greater risk for mortality in critically ill traumatic brain injury patients than in critically ill trauma patients without brain injury
20237 citationsauthor #9
Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5
202310 citationsauthor #11
Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months
202335 citationsauthor #92
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years — IVY Network, 20 U.S. States, February 2022–May 2023
202369 citationsauthor #6
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
202337 citationsauthor #21
2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023
20230 citationsauthor #4
Real-world data to evaluate effects of a multi-level dissemination strategy on access, outcomes, and equity of monoclonal antibodies for COVID-19
20232 citationsauthor #8
Prophylactic Administration of Vasopressors Prior to Emergency Intubation in Critically Ill Patients: A Secondary Analysis of Two Multicenter Clinical Trials
20238 citationsauthor #29
A multimodal strategy to improve race/ethnic group equity in administration of neutralizing monoclonal antibody treatment for COVID-19 outpatients
20234 citationsauthor #7
Individualized Treatment Effects of Bougie vs Stylet for Tracheal Intubation in Critical Illness.
202324 citationsauthor #9
Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study
202398 citationsauthor #10
Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults.
2023199 citationsauthor #42
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
202313 citationsauthor #69
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19
202314 citationsauthor #13
Tixagevimab/cilgavimab for preventing COVID-19 during the Omicron surge: retrospective analysis of National Veterans Health Administration electronic data
202310 citationsauthor #10
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.
2023196 citationsauthor #6
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
202329 citationsauthor #146
Real-world use of nirmatrelvir–ritonavir: who benefits?
20233 citationsauthor #2
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
202327 citationsauthor #23
Modifiable in‐hospital factors for 12‐month global cognition, post‐traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID‐19
20234 citationsauthor #9
Market Analysis of Video Laryngoscopy Equipment for the Role 1 Setting.
20232 citationsauthor #5
Laryngoscopy and Tracheal Intubation: Does Use of a Video Laryngoscope Facilitate Both Steps of the Procedure?
202314 citationsauthor #10
1565: A SUB-ANALYSIS OF SEVERE TRAUMATIC BRAIN INJURY PATIENTS ENROLLED IN THE SAVE-O2 RANDOMIZED TRIAL
20230 citationsauthor #14
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
202329 citationsauthor #21
Integrating physical therapy into an emergency department: A clinical pilot program
20233 citationsauthor #8
Time for the Department of Defense to Field Video Laryngoscopy Across the Battlespace.
20231 citationsauthor #6
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
202322 citationsauthor #16
43: STRATEGY TO AVOID EXCESSIVE OXYGEN IN CRITICALLY ILL TRAUMA PATIENTS: A MULTICENTER RANDOMIZED TRIAL
20230 citationsauthor #13
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
202337 citationsauthor #5
1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza — IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 – April 11, 2023
20231 citationsauthor #6
Feasibility of conducting a military-relevant multicenter cohort study to assess outcomes of early trauma resuscitative interventions in a prolonged care civilian setting
20235 citationsauthor #18
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
202357 citationsauthor #23
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
202213 citationsauthor #79
Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
202283 citationsauthor #3
Change in effectiveness of sotrovimab for preventing hospitalization and mortality for at-risk COVID-19 outpatients during an Omicron BA.1 and BA.1.1-predominant phase
202226 citationsauthor #10
Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients
20220 citationsauthor #14
Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: A qualitative study of clinician perspectives
202210 citationsauthor #5
Analysis of stroke care among 2019-2020 national emergency medical services information system encounters.
202213 citationsauthor #6
An Innovative Civilian Research Model to Inform Combat-Relevant Prolonged Casualty Care.
20225 citationsauthor #11
“All of the things to everyone everywhere”: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19
20228 citationsauthor #7
The epidemiology and outcomes of prolonged trauma care (EpiC) study: methodology of a prospective multicenter observational study in the Western Cape of South Africa
202211 citationsauthor #18
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19
202223 citationsauthor #11
Comment on: Potentially inappropriate medications in older adults visiting a geriatric emergency department
20221 citationsauthor #2
Prolonged casualty care: Extrapolating civilian data to the military context
202210 citationsauthor #17

TIMELINE

2003 53 citations

2004 43 citations

2007 32 citations

2008 1,019 citations

2009 3,348 citations

2010 550 citations

2011 632 citations

2012 664 citations

2013 458 citations

2014 547 citations

2015 636 citations

2016 417 citations

2017 2,421 citations

2018 259 citations

2019 1,389 citations

2020 2,877 citations

2021 3,430 citations

2022 1,605 citations

2023 1,041 citations

2024 407 citations

2025 13 citations

2026 0 citations

Unknown 0 citations

A. Ginde

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT